TGTX
TG Therapeutics Inc
57.40$
-0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +293.1% | +307.5% | +30.8% | +6.9% | +220.5% | +32.6% | +32.1% | +4.3% | -17.9% | -33.8% | -78.9% | |
| – | -25.6% | -52.2% | +112.3% | -19.2% | -12.0% | +608.3% | -23.7% | -68.7% | +97.7% | +12.1% | +52.0% | |
| – | -26.3% | -52.9% | +117.2% | -19.9% | -10.7% | +607.2% | -25.1% | -68.6% | – | – | – | |
| – | – | +324.5% | -2.4% | +224.2% | -9.3% | -178.4% | – | – | – | – | – | |
| – | +127.3% | +714.8% | -99.4% | +3,941.3% | +45.6% | +172.5% | +12.3% | -96.5% | -100.0% | – | +375.6% | |
| – | +34.5% | – | -130.9% | – | -160.8% | +3,313.6% | -98.6% | +5,928.0% | +153.1% | -98.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.8% | -92.7% | +2,557.5% | -15.0% | +54.0% | +288.4% | -99.6% | -76.0% | -100.0% | – | +941.6% | |
| – | -85.7% | -87.0% | – | +0.0% | -2.7% | +37.0% | -2.5% | -102.5% | – | +449.0% | -100.0% | |
| – | +0.1% | -92.7% | +2,564.7% | -15.0% | +79.7% | +232.9% | -93.9% | -100.9% | – | +76.8% | -169.8% | |
| – | -104.3% | – | – | -144.5% | – | +523.6% | -157.7% | – | – | – | -215.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.